Auto-inhibition of verapamil metabolism in rat hepatocytes of gel entrapment culture

Biomedicine and Pharmacotherapy

Volumn 65, Issue 5, 2011, Pages 328-333

  Yin, Jian ^a   Meng, Qin ^a   Dong, Xiaomei ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Metabolic auto inhibition; Primary rat hepatocytes; Verapamil

Indexed keywords

6BETA HYDROXY TESTOSTERONE; ALPHA HYDROXYMIDAZOLAM; CYTOCHROME P450 3A; KETOCONAZOLE; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG INHIBITION; DRUG MECHANISM; DRUG METABOLISM; ENZYME INHIBITION; LIVER CELL; MALE; METABOLIC INHIBITION; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CYTOCHROME P-450 CYP3A; DRUG INTERACTIONS; GELS; HEPATOCYTES; KETOCONAZOLE; MALE; METABOLIC DETOXICATION, DRUG; RATS; RATS, SPRAGUE-DAWLEY; VERAPAMIL;

EID: 79960954014     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.04.011     Document Type: Article

References (30)

1. Basile J. The role of existing and newer calcium channel blockers in the treatment of hypertension. J Clin Hypertens (Greenwich) 2004, 6:621-629. [quiz 630-1].
2. Held C., Bjorkander I., Forslund L., Rehnqvist N., Hjemdahl P. The impact of diabetes or elevated fasting blood glucose on cardiovascular prognosis in patients with stable angina pectoris. Diabet Med 2005, 22:1326-1333.
3. Backman J.T., Olkkola K.T., Aranko K., Himberg J.J., Neuvonen P.J. Dose of midazolam should be reduced during diltiazem and verapamil treatments. Br J Clin Pharmacol 1994, 37:221-225.
4. Cook C.S., Berry L.M., Burton E. Prediction of in vivo drug interactions with eplerenone in man from in vitro metabolic inhibition data. Xenobiotica 2004, 34:215-228.
5. Wang Y.H., Jones D.R., Hall S.D. Prediction of cytochrome P450 3A inhibition by verapamil enantiomers and their metabolites. Drug Metab Dispos 2004, 32:259-266.
6. Pfister C.U., Martoni A., Zamagni C., Lelli G., De Braud F., Souppart C., et al. Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara) in breast cancer patients. Biopharm Drug Dispos 2001, 22:191-197.
7. Busse D., Fromm M.F., Morike K., Drescher S., Kuhlkamp V., Eichelbaum M. Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing. Clin Pharmacol Ther 2001, 69:324-332.
8. Lemma G.L., Wang Z., Hamman M.A., Zaheer N.A., Gorski J.C., Hall S.D. The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates. Clin Pharmacol Ther 2006, 79:218-230.
9. Guo Y., Wang H., Zhang C. Establishment of rat precision-cut fibrotic liver slice technique and its application in verapamil metabolism. Clin Exp Pharmacol Physiol 2007, 34:406-413.
10. Sun L., Zhang S.Q., Zhong D.F. In vitro identification of metabolites of verapamil in rat liver microsomes. Acta Pharmacol Sin 2004, 25:121-128.
11. Choi J.S., Burm J.P. Effect of pioglitazone on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rats. Arch Pharm Res 2008, 31:1200-1204.
12. Kroemer H.K., Gautier J.C., Beaune P., Henderson C., Wolf C.R., Eichelbaum M. Identification of P450 enzymes involved in metabolism of verapamil in humans. Naunyn Schmiedebergs Arch Pharmacol 1993, 348:332-337.
13. Ma B., Prueksaritanont T., Lin J.H. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A. Drug Metab Dispos 2000, 28:125-130.
14. Polasek T.M., Elliot D.J., Lewis B.C., Miners J.O. Mechanism-based inactivation of human cytochrome P4502C8 by drugs in vitro. J Pharmacol Exp Ther 2004, 311:996-1007.
15. Obach R.S. Prediction of human clearance of 29 drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos 1999, 27:1350-1359.
16. Shibata Y., Takahashi H., Chiba M., Ishii Y. Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method. Drug Metab Dispos 2002, 30:892-896.
17. Axelsson H., Granhall C., Floby E., Jaksch Y., Svedling M., Sohlenius-Sternbeck A.K. Rates of metabolism of chlorzoxazone, dextromethorphan, 7-ethoxycoumarin, imipramine, quinidine, testosterone and verapamil by fresh and cryopreserved rat liver slices, and some comparisons with microsomes. Toxicol In Vitro 2003, 17:481-488.
18. Berthiaume F., Moghe P.V., Toner M., Yarmush M.L. Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured in a sandwich configuration. Faseb J 1996, 10:1471-1484.
19. Berry M.N., Grivell A.R., Grivell M.B., Phillips J.W. Isolated hepatocytes - past, present and future. Cell Biol Toxicol 1997, 13:223-233.
20. Blanchard N., Richert L., Notter B., Delobel F., David P., Coassolo P., et al. Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes. Eur J Pharm Sci 2004, 23:189-199.
21. Qiu H.X., Su G.G., Tang X. Tissue-like cultures of rat hepatocytes in study of phase I and phase II drug metabolism. Zhejiang Da Xue Xue Bao Yi Xue Ban 2006, 35:541-546.
22. Shen C., Zhang G., Qiu H., Meng Q. Acetaminophen-induced hepatotoxicity of gel entrapped rat hepatocytes in hollow fibers. Chem Biol Interact 2006, 162:53-61.
23. Wu D.Q., Zhang G.L., Shen C., Zhao Q., Li H., Meng Q. Evaluation of diffusion in gel entrapment cell culture within hollow fibers. World J Gastroenterol 2005, 11:1599-1604.
24. Choi J.S., Li X. The effect of verapamil on the pharmacokinetics of paclitaxel in rats. Eur J Pharm Sci 2005, 24:95-100.
25. Liu Z.H., Zeng S. Cytotoxicity of ginkgolic acid in HepG2 cells and primary rat hepatocytes. Toxicol Lett 2009, 187:131-136.
26. Lu Y., Meng Q., Zhang G., Bei X. Clozapine-induced hepatotoxicity in rat hepatocytes by gel entrapment and monolayer culture. Toxicol In Vitro 2008, 22:1754-1760.
27. Mudra D.R., Borchardt R.T. Absorption barriers in the rat intestinal mucosa: 1. Application of an in situ perfusion model to simultaneously assess drug permeation and metabolism. J Pharm Sci 2009, 99:982-998.
28. Houston J.B. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol 1994, 47:1469-1479.
29. Naritomi Y., Terashita S., Kimura S., Suzuki A., Kagayama A., Sugiyama Y. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. Drug Metab Dispos 2001, 29:1316-1324.
30. Rippin S.J., Hagenbuch B., Meier P.J., Stieger B. Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes. Hepatology 2001, 33:776-782.